Literature DB >> 6595

Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

T Tadakuma, A L Kühner, R R Rich, J R David, C W Pierce.   

Abstract

Supernatant fluids from murine spleen cell cultures incubated with concanavalin A for 48 hr contain a factor(s), soluble immune response suppressor (SIRS), which suppresses plaque-forming cell responses to sheep erythrocytes by murine spleen cells in vitro. In the present studies, some of the biochemical and biophysical properties of SIRS were investigated. SIRS was non-dialysable; the suppressive activity was stable at 56 degrees C for 30 min, but was destroyed by treatment at 70 degrees C for 30 min, 80 degrees C for 10 min, or at pH 2. The suppressive activity was not absorbed by the stimulating antigen, SRBC, or antisera against murine IgG or mu-chain, suggesting that SIRS does not contain immunoglobulin determinants. Murine spleen and thymus, but not kidney cells, however, absorbed SIRS activity. Enzyme treatments revealed that SIRS was resistant to DNase and RNase, but was destroyed by trypsin and chymotrypsin. In gel filtration with Sephadex G-100, SIRS activity eluted in the fraction corresponding to m.w. in the range between 48,000 and 67,000. With polyacrylamide gel electrophoresis, SIRS activity migrated in the region cathodal to albumin. Isopycnic centrifugation in a cesium chloride gradient suggested that SIRS is a glycoprotein. These supernatant fluids with SIRS activity were also found to contain macrophage migration inhibitory factor (MIF). In the experiments using gel filtration, polyacrylamide gel electrophoresis, and isopycnic centrifugation to fractionate supernatant fluids, SIRS and MIF activity were found in the same fractions, and to date we have been unable to dissociate definitively SIRS activity from MIF activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6595

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Stimulation of a human B-lymphocyte line by anti-immunoglobulin and its concanavalin A-induced suppression by a T-cell line.

Authors:  T Kishimoto; P Ralph; R A Good
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro.

Authors:  R Alam; J A Grant; M A Lett-Brown
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Identification of two suppressor factors induced by early pregnancy factor.

Authors:  B E Rolfe; A C Cavanagh; K A Quinn; H Morton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

4.  Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

5.  Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

6.  Functional properties of lymphocytes isolated from murine small intestinal epithelium.

Authors:  S B Dillon; T T MacDonald
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

7.  Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.

Authors:  M Lenfant; L Millerioux; I Blazsek; N Duchange
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

8.  Macrophages: modulators of immunity. Parke-Davis Award Lecture.

Authors:  C W Pierce
Journal:  Am J Pathol       Date:  1980-01       Impact factor: 4.307

9.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

10.  Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.

Authors:  T M Aune; C W Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.